You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, look for clinical trials, and connect with others living with it — all in one place.
Open the full Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency hub →Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency is a rare condition. Also known as COXPD10, Combined oxidative phosphorylation defect type 10. Tomeko brings together the specialists, research, clinical trials, treatments and community for Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:314637 · OMIM 614702 · ICD-10 E88.8 · GARD 0017428
Start by learning the basics from an authoritative source, find a specialist or center that sees Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, filtered to your area.
Tomeko shows live, recruiting studies for Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency from ClinicalTrials.gov on the hub.